التداخل بين إسراديبين ووارفارين

Neither racemic warfarin nor isradipine binding to plasma proteins in vitro was altered by the addition of the other drug.

Warfarin: In a study in healthy volunteers, no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin (0.7 mg/kg body weight) were administered during 11 days of multiple-dose treatment with 5 mg b.i.d. isradipine.